ClinicalTrials.gg
RecruitingNCT07128966JBMRUpdated May 5, 2026

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

An observational study in Healthy, Lupus and Celiac, sponsored by Joined Bio. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by Joined Bio · Observational

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100,000
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 103 studies in Celiac Disease with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Celiac Disease · United States.

Planned enrollment
2nd of 35
100,000 · median 175
Started
2025
with 4 others
Observational
35 of 103
9 open now
Primary completion
2035-09
later than 19 of 19 live
Registered
101st of 103
by date

Among the 103 studies in Celiac Disease with a site in United States, this one is the 2nd largest by planned enrollment of the 35 observational ones that give a count, is one of 5 that started in 2025, is one of 35 observational ones, reaches primary completion later than 19 of the 19 other live ones, and was the 101st registered.

Celiac Disease

353 studies on the registry are indexed under Celiac Disease; 78 are open to participants now.

Browse Celiac Disease studies →

Open to participants now

16 of the 103 studies in Celiac Disease with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 48 Celiac Disease studies recruiting now, 24 (50%) set no upper age limit and 19 (40%) stop at 75 or younger; 16 take children under 18; 13 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 103 studies in Celiac Disease with a site in United States, or all of them as a file.
02

Study summary

This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.

Read the detailed description

Primary: The primary objective of this study is to connect participants with specific health profiles, along with biospecimens and associated de-identified health data, to scientific researchers who are searching for new diagnostics and treatments for a wide array of conditions. This will accelerate medical discovery by connecting medical research with the power of patient participation.

Secondary: The secondary objective of this study is to allow participants with specific health profiles, along with their de-identified health data, to help further the cause of medicine generally through interviews, surveys, and other minimal risk research activities desired by life science organizations.

03

Conditions studied

  • Healthy
  • Lupus
  • Celiac
  • Kidney Disease
  • Chronic
  • Dermatologic

Keywords

  • biospecimen
  • rare disease
  • participant
  • registry
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Outside of this protocol, Joined Bio is creating a network of individuals who are interested in participating in research. Individuals are recruited across a broad cross-section of ages, medical conditions, and geographic locations within the United States. These individuals voluntarily join the Joined Bio network, consent to share health information with Joined, and then securely transfer their health information to Joined Bio. All health information is stored in a de-identified manner (with the exception of dates of service, which are protected in accordance with HIPAA) and encrypted with Joined Bio holding re-identification keys.

Joined Bio then searches its network of participants to see if there are matches to the research project. If there are matches, Joined Bio re-identifies the individual and reaches out to them to let them know that they match up to a research project and also to provide them with information about the research.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female, that are adults [have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico].
  • Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
  • Be willing to comply with all study procedures and be available for the duration of the study.
  • Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
  • Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.

Exclusion criteria

Exclusion Criteria:

  • Unable to meet the Inclusion Criteria listed above.
  • Prisoners or children
  • Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes
Biospecimen retention
Samples with dna

Groups and cohorts

  • Healthy participants

    This is non-interventional, observational only research. Participants may be healthy. Participants will be invited to participate on a per-project basis, depending on the cohort requirements for the project.

    Other: Observation

  • Participants with a condition

    Participants may have a condition such as lupus, celiac, dermatitis or other condition. Participants will be invited to participate on a per-project basis, depending on the cohort requirements for the project.

    Other: Observation

Interventions

  • OtherObservation

    This is non-interventional, observational only

06

What researchers measure

Primary outcomes

  1. Observation for biomarker identification

    There is no defined study outcome. Rather this is an observational study of multiple participant populations that hopes to identify new biomarkers, treatments and/or diagnostic applications.

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
  • Joined Bio
    Lexington, Massachusetts 02420, United States
    Recruiting
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Sep 2035, 125 months after the start.

Of 48 observational studies under Celiac Disease, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 83. This study's planned 125 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2025
First posted
Aug 19, 2025
StartActual
Apr 1, 2025
Primary completionEst.
Sep 1, 2035
CompletionEst.
Sep 1, 2036
Last update
May 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07128966
Lead sponsor
Joined Bio
Responsible party
Sponsor
First posted
Aug 19, 2025
Start date
Apr 1, 2025
Primary completion
Sep 1, 2035 (estimated)
Completion
Sep 1, 2036 (estimated)
Last update
May 5, 2026

Study contacts

Emily L Hubbard, BS Biology
Contact
ehubbard@joined.bio
12567970003
Jill Mullan
Contact
jmullan@joined.bio
Chris Ianelli, MD
principal investigator · Joined Bio

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion